Elypta

48 posts

Elypta banner
Elypta

Elypta

@ElyptaDx

The official account for Elypta. Our mission is to enable early detection and closer monitoring of cancer.

Stockholm Katılım Kasım 2018
28 Takip Edilen118 Takipçiler
Elypta retweetledi
IKCC Kidney Cancer
IKCC Kidney Cancer@IKCCorg·
Calling all patients with advanced #kidneycancer. Please consider taking part in this important piece of research by the European Oncology Nursing Society @cancernurseEU @nursGK704
Celia Díez De los Ríos@PotisDR

HELP NEEDED!!! Are you an adult living with advanced #renalcancer or advanced #livercancer ? We opened our international #survey. Please have your say - help us better understand your experiences - make us better for you. 👉glasgow-research.onlinesurveys.ac.uk/proms-for-rcch… @nursGK704 @cancernurseEU

English
0
3
4
0
Elypta
Elypta@ElyptaDx·
We just closed a $21 million series A! We couldn’t be more excited as it allows us to complete development in two indications - Multi Cancer Early Detection and surveillance of kidney cancer recurrence. Delighted to have @BonnierVentures as our new lead bit.ly/39yUFha
English
1
2
10
0
Elypta
Elypta@ElyptaDx·
Are you in Copenhagen? Do not miss our co-founder and CSO @gattofr at Talks at the Square at the @BioCPH on September 6! Limited free tickets here: lnkd.in/ebyHmveg
English
0
1
2
0
Elypta
Elypta@ElyptaDx·
@DrCraigGedye Valid question! Was any propensity score-matching done to balance patient characteristics between Cohort A and B? Is it known what was the most common decision criterion to allocate a mRCC patient to active surveillance?
English
1
0
1
0
Craig Gedye
Craig Gedye@DrCraigGedye·
And now the questions really start... Can we accurately predict who needs treatment or who can wait? How often should people who 'wait and see' be seen by their doctor? How often should they take scans? Are there any blood tests that might help advise these people? @ElyptaDx 8/
GIF
English
2
0
1
0
Craig Gedye
Craig Gedye@DrCraigGedye·
Wait and see #2. A second large prospective registry study of #activesurveillance in #advanced #metastatic #kidneycancer from the #MaRCC registry 1/ ncbi.nlm.nih.gov/pmc/articles/P… @IKCCorg @ANZUPtrials
Craig Gedye@DrCraigGedye

Wait and see. People with #kidneycancer that has spread might be able to delay starting #treatment. Biggest study to date on #activesurveillance shows people that started treatment >6m after diagnosis did no worse than people starting drugs immediately clinical-genitourinary-cancer.com/article/S1558-… 1/

English
1
0
0
0
Elypta
Elypta@ElyptaDx·
Our CSO @gattofr is presenting at the #EAU21 Poster Session 22 at 5.46 PM CET the study "Urine free glycosaminoglycans as monitoring biomarkers in confined renal cell carcinoma - A prospective observational study" lnkd.in/dswaUDj
English
0
1
3
0
Elypta
Elypta@ElyptaDx·
100 patients! Elypta is proud to announce that our flagship study AURORAX-0087A (EU grant 849251) has today included its 100th patient. So grateful to the principal investigators, their staff, and patients for their incredible efforts! bit.ly/2SFWj89
English
1
3
7
0
Elypta
Elypta@ElyptaDx·
We shared some exciting results at ASCO earlier in June. A study across 14 cancers and more than 1500 samples in total showed our GAGome platform’s ability to detect 1/3 stage 1 tumors. A breakthrough in our mission to enable early detection of cancer. firstwordmedtech.com/node/1046944?t…
English
0
1
1
0
Elypta retweetledi
nina.capital
nina.capital@ninacapital·
🥁 Calling #healthtech entrepreneurs, investors, advisors or professionals in a corporate environment in Europe and/or in the US! We would appreciate if you could fill out this survey to support our analyst intern @lesley_farrah for her Master thesis. forms.gle/a6jhqndnq1QKwu…
English
0
5
5
0
Elypta
Elypta@ElyptaDx·
We have some good news to share. Our glycosaminoglycan profiling kit is now available as a service for the research community. GAGs play a role in many conditions and we believe standardized, accurate quantification can help others explore this. elypta.com/news-blog/2021…
English
0
3
5
0
Elypta
Elypta@ElyptaDx·
Elypta is happy to share the progress on the AURORAX-0087A study (co-funded by EU SME Instr. 2 Grant No 849251) that is now active in nearly all 16 sites! #liquidbiopsy #rcc #eu #horizon2020
Elypta tweet media
English
0
0
7
0

Keşfet

@cancernurseEU @nursGK704 @BonnierVentures @SofinnovaVC @Siftedeu @BioCPH @DrCraigGedye @IKCCorg